Insider Selling: Anthony N. Truesdale Unloads 35,000 Shares of Vitamin Shoppe Stock (VSI)
Vitamin Shoppe (NYSE:VSI) CEO Anthony N. Truesdale unloaded 35,000 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $48.51, for a total value of $1,697,850.00. Following the transaction, the chief executive officer now directly owns 107,447 shares in the company, valued at approximately $5,212,254. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
VSI has been the subject of a number of recent research reports. Analysts at Goldman Sachs Group Inc. upgraded shares of Vitamin Shoppe from a “buy” rating to a “conviction-buy” rating in a research note to investors on Monday, November 18th. They now have a $65.00 price target on the stock, up previously from $59.00. Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of Vitamin Shoppe in a research note to investors on Wednesday, November 6th. They now have a $42.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of Vitamin Shoppe from $52.00 to $55.00 in a research note to investors on Wednesday, November 6th. They now have a “buy” rating on the stock. Two investment analysts have rated the stock with a sell rating, six have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Vitamin Shoppe currently has an average rating of “Buy” and an average price target of $54.48.
Shares of Vitamin Shoppe (NYSE:VSI) traded down 3.33% on Monday, hitting $46.40. 561,711 shares of the company’s stock traded hands. Vitamin Shoppe has a 52-week low of $39.92 and a 52-week high of $65.93. The stock’s 50-day moving average is $52.23 and its 200-day moving average is $46.99. The company has a market cap of $1.393 billion and a P/E ratio of 22.61.
Vitamin Shoppe (NYSE:VSI) last released its earnings data on Tuesday, November 5th. The company reported $0.53 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.52 by $0.01. The company had revenue of $272.50 million for the quarter, compared to the consensus estimate of $273.87 million. During the same quarter in the previous year, the company posted $0.54 earnings per share. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. Analysts expect that Vitamin Shoppe will post $2.28 EPS for the current fiscal year.
Vitamin Shoppe, Inc is a specialty retailer and direct marketer of vitamins, minerals, herbs, specialty supplements, sports nutrition and other health and wellness products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.